Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Lars Tatenhorst, Katrin Eckermann, Vivian Dambeck, et al.
Acta Neuropathologica Communications (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 140

Showing 51-75 of 140 citing articles:

Rodent models for gait network disorders in Parkinson's disease – a translational perspective
Nikolaus Wenger, Arend Vogt, Matej Skrobot, et al.
Experimental Neurology (2022) Vol. 352, pp. 114011-114011
Open Access | Times Cited: 18
The potential therapeutic roles of Rho GTPases in substance dependence
Qin Ru, Yu Wang, Enyuan Zhou, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 9
Neuroprotective Effect of Mangiferin against Parkinson’s Disease through G-Protein-Coupled Receptor-Interacting Protein 1 (GIT1)-Mediated Antioxidant Defense
Hang Zhou, Mao Zhang, Xiaonan Zhang, et al.
ACS Chemical Neuroscience (2023)
Closed Access | Times Cited: 9
Neurodegenerative Disease Associated Pathways in the Brains of Triple Transgenic Alzheimer’s Model Mice Are Reversed Following Two Weeks of Peripheral Administration of Fasudil
Richard Killick, Christina Elliott, Elena M. Ribé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11219-11219
Open Access | Times Cited: 9
New therapies on the horizon: Targeted protein degradation in neuroscience
James A Gregory, Christopher M. Hickey, Juan D. Chavez, et al.
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1688-1698
Open Access | Times Cited: 3
Small Molecules, α-Synuclein Pathology, and the Search for Effective Treatments in Parkinson’s Disease
GianPietro Sechi, Maria Margherita Sechi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11198-11198
Open Access | Times Cited: 3
A refined concept: α-synuclein dysregulation disease
Hideki Mochizuki, Chi‐Jing Choong, Eliezer Masliah
Neurochemistry International (2018) Vol. 119, pp. 84-96
Open Access | Times Cited: 30
A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
Karima Schwab, Silke Frahm, David A. Horsley, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 10
Open Access | Times Cited: 29
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
Karina Joppe, Lars Tatenhorst, Lucas Caldi Gomes, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 3, pp. 554-573
Open Access | Times Cited: 20
How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review
Tracy D. Zhang, Scott Kolbe, Leah C. Beauchamp, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3026-3026
Open Access | Times Cited: 15
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
Natalia Siwecka, Kamil Saramowicz, Grzegorz Galita, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2051-2051
Open Access | Times Cited: 8
A small molecule 20C from Gastrodia elata inhibits α-synuclein aggregation and prevents progression of Parkinson’s disease
Ye Peng, Jun-rui Ye, Shasha Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 8
Rho‐associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease
Aaron Y. Lai, JoAnne McLaurin
Journal of Neurochemistry (2017) Vol. 144, Iss. 5, pp. 659-668
Open Access | Times Cited: 27
Systematic data analysis and data mining in CatWalk gait analysis by heat mapping exemplified in rodent models for neurodegenerative diseases
Ivanna K. Timotius, Fabio Canneva, Georgia Minakaki, et al.
Journal of Neuroscience Methods (2019) Vol. 326, pp. 108367-108367
Closed Access | Times Cited: 23
The onjisaponin B metabolite tenuifolin ameliorates dopaminergic neurodegeneration in a mouse model of Parkinson’s disease
Fang Peng, Linyu Lu, Fei Wei, et al.
Neuroreport (2020) Vol. 31, Iss. 6, pp. 456-465
Closed Access | Times Cited: 23
Crocin Inhibits the Fibrillation of Human α-synuclein and Disassembles Mature Fibrils: Experimental Findings and Mechanistic Insights from Molecular Dynamics Simulation
Babak Saffari, Mehriar Amininasab
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 21, pp. 4037-4057
Closed Access | Times Cited: 18
The Strategies of Development of New Non-Toxic Inhibitors of Amyloid Formation
Oxana V. Galzitskaya, Sergei Y. Grishin, Anna V. Glyakina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3781-3781
Open Access | Times Cited: 7
Protein aggregation-inhibition: a therapeutic route from Parkinson’s disease to sickle cell anemia
Gabriel F. Martins, Nuno Galamba
Critical Reviews in Biochemistry and Molecular Biology (2023) Vol. 58, Iss. 1, pp. 50-80
Open Access | Times Cited: 7
Baijiu hangover: Correlation analysis between neurobiochemical and behavioral parameters in a mouse model and clinical symptoms
Yufei Liu, Qingxi Ren, Zhilei Zhou, et al.
Food Bioscience (2024) Vol. 59, pp. 103799-103799
Closed Access | Times Cited: 2
Substance Addiction Rehabilitation Drugs
Shu Yuan, Sicong Jiang, Zhongwei Zhang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 615-615
Open Access | Times Cited: 2
Fasudil alleviates alcohol-induced cognitive deficits and hippocampal morphology injury partly by altering the assembly of the actin cytoskeleton and microtubules
Yu Cai, Lu-Wan Wang, Jing Wu, et al.
Behavioural Brain Research (2024) Vol. 471, pp. 115068-115068
Closed Access | Times Cited: 2
Inhibitor Development for α-Synuclein Fibril’s Disordered Region to Alleviate Parkinson’s Disease Pathology
Shenqing Zhang, Huaijiang Xiang, Youqi Tao, et al.
Journal of the American Chemical Society (2024)
Open Access | Times Cited: 2
Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases
Qiuyan Ye, Xue Li, Wei Gao, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Rho‐associated coiled‐coil kinase 1 activation mediates amyloid precursor protein site‐specific Ser655 phosphorylation and triggers amyloid pathology
Yongbo Hu, Ru‐Jing Ren, Yong‐Fang Zhang, et al.
Aging Cell (2019) Vol. 18, Iss. 5
Open Access | Times Cited: 22
Antidepressant-relevant behavioral and synaptic molecular effects of long-term fasudil treatment in chronically stressed male rats
Luciano Román-Albasini, Gabriela Dı́az-Véliz, Felipe A. Olave, et al.
Neurobiology of Stress (2020) Vol. 13, pp. 100234-100234
Open Access | Times Cited: 20

Scroll to top